A Phase IV Study of the Safety and Feasibility of Rooms-Based Infusion of Zoledronic Acid for Women With Post-Menopausal Osteoporosis.
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms LISA
- Sponsors Novartis
- 01 Feb 2012 Actual patient number (186) added as reported by ClinicalTrials.gov.
- 01 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.